Get the app!
Back to Trades

Reardon Andrew

CLO & SecretaryCIK 0001950232

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
10
Buy transactions
0
Sell transactions
73
Companies
1
Active
2025–2026

Across 10 filings between 2025–2026, Reardon Andrew, CLO & Secretary, has disclosed $15.8M in transactions — all concentrated in LIGAND PHARMACEUTICALS INC (LGND). Their disclosed trades are heavily weighted toward selling — $0 in buys and $11.9M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

10 loaded
Nov 4LGND
LIGAND PHARMACEUTICALS INC
Reardon AndrewCLO & SecretarySell$1.6M
Oct 6LGND
LIGAND PHARMACEUTICALS INC
Reardon AndrewCLO & SecretarySell$1.5M
Sep 8LGND
LIGAND PHARMACEUTICALS INC
Reardon AndrewCLO & SecretarySell$1.4M
Aug 4LGND
LIGAND PHARMACEUTICALS INC
Reardon AndrewCLO & SecretarySell$1.4M
Jul 6LGND
LIGAND PHARMACEUTICALS INC
Reardon AndrewCLO & SecretarySell$1.6M
Jun 2LGND
LIGAND PHARMACEUTICALS INC
Reardon AndrewCLO & SecretarySell$1.1M
May 4LGND
LIGAND PHARMACEUTICALS INC
Reardon AndrewCLO & SecretarySell$1.2M
Apr 2LGND
LIGAND PHARMACEUTICALS INC
Reardon AndrewCLO & SecretarySell$1.0M
Mar 6LGND
LIGAND PHARMACEUTICALS INC
Reardon AndrewCLO & SecretarySell$1.0M
Aug 12LGND
LIGAND PHARMACEUTICALS INC
Reardon AndrewCLO & SecretaryTax withheld$198.8K

10 filings